Chen et al. (2017) investigated that irinotecan with simvastatin30 in PC3 and DU145 prostate cancer cell lines and in another study Atorvastatin alone inhibit the expression of HIF‐1α protein level and increase hypoxia‐induced prostate cancer cells.31 The gene discussed is HIF1A; the disease is prostate carcinoma.